How To Know If You Can Get Better From A Heart Attack

Transcription

1 Publicaties 2013 Dissertaties 2013 Vermeulen RP Quality management developments in cardiology ISBN: Promotiedatum: 13 februari 2013 Promotores: Copromotores: Prof.dr. M.P. van den Berg Dr. B.J.G.L. de Smet Dr. M.W.N. Nijsten Lok DJA Novel markers in chronic heart failure ISBN: Promotiedatum: 22 mei 2013 Promotores: Prof.dr. D.J. van Veldhuisen Dr. P. van der Meer Van Deursen VM Comorbidity in heart failure ISBN ISBN (PDF) ISBN (epub) Promotiedatum: 26 juni Promotores: Prof.dr. A.A. Voors Prof.dr. D.J. van Veldhuisen Copromotor: Dr. K. Damman De Vries, AE The use of computer decision support systems and telemonitoring in heart failure ISBN ISBN (electronic) Promotiedatum: 4 september 2013 Promotores: Prof.dr. H.L. Hillege Prof.dr. T. Jaarsma Prof.dr. R.J.J.M. Jorna Copromotor: Dr. M.H.L. van der Wal Fokkema ML Outcome after percutaneous coronary intervention ISBN: ISBN electronic version: Promotiedatum: 20 februari 1986 Promotores: Prof.dr. A.A. Voors Copromotor: Dr. B.J.G.L. de Smet Gu YL Intracoronary therapies & myocardial reperfusion in acute myocardial infarction ISBN: ISBN electronic version: Promotiedatum: 20 november 2013

2 Promotor: Copromotores: Prof.dr. F. Kuipers Dr. B.J.G.L. de Smet Dr. I.C.C. van der Horst Internationale tijdschriften Posafalvi A, Herkert JC, Sinke RJ, Van den Berg MP, Mogensen J, Jongbloed JD, Van Tintelen JP Clinical utility gene card for: dilated cardiomyopathy (CMD). Eur J Human Gen 2013;21: Engels GE, Gu YJ, Van Oeveren W, Rakhorst G, Mariani MA, Erasmus ME The utility of lung epithelium specific biomarkers in cardiac surgery: a comparison of biomarker profiles in on- and off-pump coronary bypass surgery. J Cardiothorac Surg 2013;8:4 Metra M, Cotter G, Davison BA,, Voors AA, et al Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX- AHF) development program: correlation with outcomes. J Am Coll Cardiol 2013;2: Freling HG, Pieper PG, Vermeulen KM, Van Swieten JM, Sijens PE, Van Veldhuisen DJ, Willems TP Improved cardiac MRI volume measurements in patients with Tetralogy of Fallot by independent endsystolic and end-diastolic phase selection. PLoS One 2013;8 De Laat MWM, Pieper PG, Oudijk MA, Mulder BJM, Christoffels VM, Afink GB, Postma AV, Ris-Stalpers C The clinical and molecular relations between idiopathic preterm labor and maternal congenital heart disease. Reprod Sc 2013;2: De Vries AE, Van der Wal MHL, Nieuwenhuis MMW, De Jong RM, Van Dijk RB, Jaarsma T, Hillege HL Health professionals expectations versus experiences of internet-based telemonitoring: survey among heart failure clinics. J Med Intern Res 2013;1:73-83 Sinner MF, Wang N, Fox CS, Fontes JD, Rienstra M, Magnani JW, Vasan RS, Calderwood AH, Pencina M, Sullivan LM, Ellinor PT, Benjamin EJ Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation. Am J Cardiol 2013;2: Groenweg JA, Van der Zwaag PA, Jongbloed JD, Cox MG, Vreeker A, De Boer RA, Van der Heijden JF, Van Veen TA, McKenna WJ, Van Tintelen JP, Dooijes D, Hauer RN Left-dominant arrhythmogenic cardiomyopathy in a large family: associated desmosomal or nondesmosomal genotype? Heart Rhythm 2013;10:548-59

3 Zuidersma M, Conradi HJ, Van Melle JP, Ormel J, De Jonge P Depression treatment after myocardial infarction and long-term risk of subsequent cardiovascular events and mortality: a randomized controlled trial. J Psychosom Res 2013;74:25-30 Manhenke C, Orn S, Von Haehling S, Wollert KC, Ueland T, Aukrust P, Voors AA, Squire I, Zannad F, Anker SD, Dickstein K Clustering of 37 circulating biomarkers by exploratory factor analysis in patients following complicated acute myocardial infarction. Int J Cardiol 2013;166: Van Veldhuisen DJ, McMurray JJ Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel? Eur J Heart Fail 2013;15:5-8 Udo EA, Van Hemel NM, Zuithoff NPA, Dijk WA, Hooijschuur CAM, Doevendans PA, Moons KGM Pacemaker follow-up: are the latest guidelines in line with modern pacemaker practice? Europace 2013;2: Westenbrink BD, Dorn GW Imaging the cardiac diet. Eur J Heart Fail 2013;2:123-4 Van der Bom T, Winter MM, Bouma BJ, Groenink M, Vliegen HW, Pieper PG, Van Dijk APJ, Sieswerda GT, Roos-Hesselink JW, Zwinderman AH, Mulder BJM Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation 2013;3: Hyttel-Sorensen S, Austin T, Van Bel F, Benders M, Claris O, Dempsey EM, Fumagalli M, Gluud C, Hagmann C, Hellström-Westas L, Lemmers P, Naulaers G, Van Oeveren W, Pellicer A, Pichler G, Roll C, Støy LS, Wolf M, Greisen G Clinical use of cerebral oximetry in extremely preterm infants is feasible. Dan Med J 2013;60:A4533 Kneyber MC, Grotenhuis F, Berger RF, Ebels TW, Burgerhof JG, Albers MJ Transfusion of leukocyte-depleted RBC s is independently associated with increased morbidity after pediatric cardiac surgery. Pediatr Crit Care Med 2013;14: Gheorghiade M, Marti CN, Sabbah HN, Roessig L, Greene SJ, Böhm M, Burnett JC, Campia U, Cleland JG, Collins SP, Fonarow GC, Levy PD, Metra M, Pitt B, Ponikowski P, Sato N, Voors AA, Stasch JP, Butler J Soluble guanylate cyclase: a potential therapeutic target for heart failure. Heart Fail Rev 2013;18: Swedberg K, Young JB, Anand IS,, Van Veldhuisen DJ Treatment of anemia with darbepoetin alfa in systolic heart failure. N Eng J Med 2013;13:1210-9

4 Lubitz SA, Rienstra M Genetic susceptibility to atrial fibrillation: does heart failure change our perspective? Eur J Heart Fail 2013;3:244-6 Heuvelman HJ, Arabkhani B, Cornette JMJ, Pieper PG, Bogers AJJC, Takkenberg JJM, Roos-Hesselink JW Pregnancy outcomes in women with aortic valve substitutes. Am J Cardiol 2013;3:382-7 Mahmud H, Ruifrok WP, Westenbrink BD, Cannon MV, Vreeswijk-Baudoin I, Van Gilst WH, Silljé HH, De Boer RA Suicidal erythrocyte death, eryptosis, as a novel mechanism in heart-failure associated anaemia. Cardiovasc Res 2013;98:37-46 Broekema FI, Van Oeveren W, Selten MH, Meijer RJ, De Wolf JT, Bos RR In vivo hemostatic efficacy of polyurethane foam compared to collagen and gelatin. Clin Oral Investig 2013;17: Erqou S, Lee CT,Suffoletto M, Echouffo-Tcheugui JB, De Boer RA, Van Melle JP, Adler AI Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: systematic review and meta-analysis Eur J Heart Fail 2013;15: Pieper PG Predicting the future in peripartum cardiomyopathy. Heart 2013;5:295-6 Lau CP, Gbadebo TD, Connolly SJ, Van Gelder IC, Capucci A, Gold MR, Israel CW, Morillo CA, Siu CW, Abe H, Carlson M, Tse HF, Hohnloser SH, Healey JS; ASSERT investigators Ethnic differences in atrial fibrillation using implanted cardiac devices. J Cardiovasc Electrophysiol 2013;24:381-7 Teerlink JR, Cotter G, Davison BA,, Voors AA, et al Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 2013;381:29-39 Van Veldhuisen DJ, Linssen GCM, Jaarsma T, Van Gilst WH, Hoes AW, Tijssen JGP, Paulus WJ, Voors AA, Hillege HL B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol 2013;14: Kottgen A, Albrecht E, Teumer A,, Van der Harst P, et al Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 2013;2: Groeneweg JA, Van der Zwaag PA, Jongbloed JD, Cox MG, Vreeker A, De Boer RA, Van der Heijden JF, Van Veen TA, McKenna WJ, Van Tintelen JP, Dooijes D, Hauer RN Left-dominant arrhythmogenic cardiomyopathy in a large family: associated desmosomal or nondesmosomal genotype? Heart Rhythm 2013;10:548-9

5 Fokkema ML, James SK, Albertsson P, Akerblom A, Cailas F, Eriksson P, Jensen J, Nilsson T, De Smet BJ, Sjogren I, Thorvinger B, Lagerqvist B Population trends in percutaneous coronary intervention; 20-year results from the SDCAAR (Swedish Coronary Angiography and Angioplasty Registry. J Amer Coll Cardiol 2013;12: Hummel YM, Wilde AA, Voors AA, Bugatti S, Hillege JL, Van den Berg MP Ventricular dysfunction in a family with long QT syndrome type 3. Europace 2013;15: Kortekaas KA, Hoogslag GE, De Boer RA, Dokter MM, Versteegh MI, Braun J, Marsan NA, Verwey HF, Delgado V, Schalij MJ, Klautz RJ Galectin-3 and left ventricular reverse remodelling after surgical mitral valve repair. Eur J Heart Fail 2013;15: Mulder BA, Schnabel RB, Rienstra M Predicting the future in patients with atrial fibrillation: who develops heart failure? Eur J Heart Fail 2013;4:366-7 Hoendermis ES, Van Melle JP Impaired right ventricular function and elevated pulmonary artery pressure: a lethal combination. Eur J Heart Fail 2013;25:363-5 McMurray JJ, Anand IS, Diaz R, Maggione AP, O Connor C, Pfeffer MA, Solomon SD, Tendera M, Van Veldhuisen DJ, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB; on behalf of the RED-HF Committees Investigators Baseline characteristics of patients in the reduction of events with darbepoetin alfa in heart failure trial (RED-HF). Eur J Heart Fail 2013;15: Roberts JD, Herkert JC, Rutberg J, Nikkel SM, Wiesfeld ACP, Dooijes D, Gow RM, Van Tintelen JP, Gollob MH Detection of genomic deletions of PKP2 in arrhytmogenic right ventricular cardiomyopathy. Clin Genet 2013;5:452-6 Szymanski MK, Hillege HL, Danser AHJ, Garrelds IM, Schoemaker RG Elevated sensitivity to cardiac ischemia in proteinuric rats is independent of adverse cardiac remodeling. J Hypertens 2013;5: Hoekstra T, Jaarsma T, Van Veldhuisen DJ, Hillege HL, Sanderman R, Lesman-Leegte I Quality of life and survival in patients with heart failure. Eur J Heart Fail 2013;15: Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, Lok DJ, Rosentryt P, Torrens A, Polonski L, Van Veldhuisen DJ, Van der Meer P, Jankowska EA Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J 2013;4: Hoen PW, Rosmalen JGM, Schoevers RA, Huzen J, Van der Harst P, De Jonge P Association between anxiety but not depressive disorders and leukocyte telomere length after 2 years of follow-up in a population-bases sample. Psychol Med 2013;4:689-97

6 Kleijn L, Westenbrink BD, Van der Meer P Erythropoietin and heart failure: the end of a promise? Eur J Heart Fail 2013;5: Koene BM, Soliman Hamad MA, Bouma W, Mariani MA, Peels KC, Van Dantzig JM, Van Straten AH Impact of prosthesis-patient mismatch on early and late mortality after aortic valve replacement. J Cardiothorac Surg 2013;8:96 De Vries AE, Van der Wal MHL, Nieuwenhuis MMW, De Jong RM, Van Dijk RB, Jaarsma T, Hillege HL Perceived barriers of heart failure nurses and cardiologists in using clinical decision support systems in the treatment of heart failure patients. BMC Medical Inform Decis Mak 2013;13:54 Arsov S, Graaff R, Van Oeveren W, Steghmayr B, Sikole A, Rakhorst G, Smit AJ Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review. Clin Chem Lab Med 2013;4:1-10 Westenbrink BD, Edwards AG, Miyamoto S Conference report from the 2012 AHA scientific sessions in Los Angeles. Expert Opin Ther Targets 2013;6:733-7 Metra M, Cotter G, Davison BA,, Voors AA, et al Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX- AHF) development program: correlations with outcomes. J Am Coll Cardiol 2013;61: Dobre D, Rossignol P, Murin J, Parkhomenko A, Lamiral Z, Krum H, Van Veldhuisen DJ, Pitt B, Zannad F Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trial. Eur J Heart Fail 2013;15:221-7 Johansson P, Lesman-Leegte I, Lundgren J, Hillege HL, Hoes A, Sanderman R, Van Veldhuisen DJ, Jaarsma T Time-course of depressive symptoms in patients with heart failure. J Psychosom Res 2013;3: Freling HG, Van Wijk K, Jaspers K, Pieper PG, Vermeulen KM, Van Swieten JM, Willems TP Impact of right ventricular endocardial trabeculae on volumes and function assessed by CMR in patients with tetralogy of Fallot. Int J Cardiovasc Imaging 2013;3: Groeneweg JA, Van der Zwaag, PA, Olde Nordkamp LR,, Wiesfeld AC,, Van den Berg MP, et al Arrhythmogenic right ventricle dysplasia/cardiomyopathy according to revised 2010 Task Force criteria with inclusion of non-desmosomal phospholamban mutation carriers. Am J Cardiol 2013;112: Ganesh SK, Tragante V, Guo W,, Van der Harst P, et al Loci influencing blood pressure identified using a cardiovascular gene-centric array. Hum Mol Genet 2013;8:

7 Hernández-Madrid, A, Svendsen JH, Lip GY, Van Gelder IC, Dobreanu D, Blomstrom-Lundqvist C Scientific Initiatives Committee, European Heart Rhythm Association (EHRA) Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey. Europace 2013;15:915-8 Testani JM, Damman K Venous congestion and renal function in heart failure it s complicated. Eur J Heart Fail 2013;6: Haase M, Muller C, Damman K, Murray PT, Kellum JA, Ronco C, McCullough PA Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: Workgroup Statements from the Eleventh Conference of the Acute Dialysis Quality Initiative (ADQi). Contrib Nephrol 2013;182: Van der Meer P, Postmus D, Ponikowski P,, Voors AA The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol 2013;19: Joosten MM, Gansevoort RT, Mukamal KJ, Van der Harst P, Geleijnse JM, Feskens EJM, Navis G, Bakker SJL Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr 2013;6: Schroten NF, Ruifrok WP, Kleijn L, Dokter MM, Silljé HH, Lambers Heerspink HJ, Bakker SJ, Kema IP, Van Gilst WH, Van Veldhuisen DJ, Hillege HL, De Boer RA Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J 2013;166: Vida VL, Torregrossa G, De Franceschi, Padalino MA, Belli E, Berggren H, ÇiÇek S, Ebels T, Fragata J, Hoel TN, Horer J, Hraska V, Kostolny M, Lindberg H, Mueller C, Pretre R, Rosser B, Rubay J, Schreiber C, Speggiorin S, Tlaskal T, Stellin G; European Congenital Heart Surgeons Association (ECHSA) Pediatric coronary artery revascularization: a European multicenter study. Ann Thorac Surg 2013;96: Delewi R, IJff G, Van de Hoef TP, Hirsch A, Robbers LF, Nijveldt R, Van der Laan AM, Van der Vleuten PA, Lucas C. Tijssen JGP, Van Rossum AC, Zijlstra F, Piek JJ Pathological Q waves in myocardial infarction in patients treated by primary PCI. JACC Cardiovasc Imaging 2013; Den Dekker MAM, Van den Dungen JJAM, Tielliu IFJ, Tio RA, Jaspers MMJJR, Oudkerk M, Vliegenthart R Prevalence of severe subclinical coronary artery disease on cardiac CT and MRI in patients with extracardiac arterial disease. Eur J Vasc Endovasc Surg 2013;6:680-9 Meissner M, Wolters H, De Boer RA, Havinga R, Boverhof R, Bloks VW, Kuipers F, Groen AK Bile acid sequestration normalizes plasma cholesterol in hypercholesterolemic mice. No additional effect of physical activity. Atherosclerosis 2013;228:117-23

8 Rienstra M, Van Gelder IC A specialized atrial fibrillation clinic: improving care and costs for patients with atrial fibrillation. Europace 2013;15: Brignole A, Aurricchio A, Baron-Esquivias G,, Van Gelder IC, et al 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013;34: Minkman MMN, Vermeulen RP, Ahaus KTB, Huijsman R A survey study to validate a four phases development model for integrated care in the Netherlands. BMC Health Serv Res 2013;13:214 Fontes JD, Yamamoto JF, Larson MG, Wang N, Dallmeier D, Rienstra M, Schnabel RB, Vasan RS, Keaney JF, Benjamin EJ Clinical correlates of change in inflammatory biomarkers: the Framingham heart study. Atherosclerosis 2013;1: Gui J, Moore JH, Williams SM, Andrews P, Hillege HL, Van der Harst P, Navis G, Van Gilst WH, Asselbergs FW, Gilbert-Diamond D A simple and computationally efficient approach to multifactor dimensionality reduction analysis of genegene interactions for quantitative traits. PLoS One 2013;8 Kerdijk W, Rio RA, Mulder BF, Cohen-Schotanus J Cumulative assessment: strategic choices to influence students study effort. BMC Med Educ 2013:13:172 McCullough PA, Kellum JA, Haase M,, Damman K, et al Pathophysiology of the cardiorenal syndromes: executive summary from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQi). Contrib Nephrol 2013;182:82-98 Gheorghiade M, Fonarow GC, Van Veldhuisen DJ, Cleland JGF, Butler J, Epstein AE, Patel K, Aban IB, Aronow WS, Anker SD. Ahmed A Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial. Eur Heart J 2013;20:1489 Berndt SI, Gustafsson S, Magi R,, Van der Harst P, et al Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nature Genet 2013;5:501-U69 Franken R, Den Hartog AW, Van de Riet L, Timmermans J, Scholte AJ, Van den Berg MP, De Waard V, Zwinderman AH, Groenink M, Yip JW, Mulder BJM Clinical features differ substantially between Caucasian and Asian populations of Marfan syndrome. Circ J 2013;11:2793-8

9 Collier TJ, Pocock SJ, McMurray JJ, Zannad F, Krum H, Van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pitt B The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial. Eur Heart J 2013;34: Van der Bom T, Winter MM, Groenink M, Vliegen HW, Pieper PG, Van Dijk APJ, Sieswerda GT, Roos- Hesselink JW, Zwinderman AH, Mulder BJM, Bouma BJ Right ventricular end-diastolic volume combined with peak systolic blood pressure during exercise identifies patients at risk for complications in adults with a systemic right ventricle. J Am Coll Cardiol 2013;10: Randall JC, Winkler TW, Kutalik Z,, Van der Harst P, et al Sex-stratified genome-wide association studies including individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet 2013;6 Westenbrink BD, Kleijn L, Van der Meer P Haemodilution is a mechanism of anaemia in patients with heart failure: reply. Eur J Heart Fail 2013;9: Schnabel RB, Rienstra M, Sullivan LM, et al Risk assessment for incident heart failure in individuals with atrial fibrillation. Eur J Heart Fail 2013;8:843-9 Salzberg SP, Van Bowen WJ, Driessen AH, Benussi S, Ylmaz A, Mariani M, Hyde J, Hunter S, Castella M Atrio-esophageal fistula following minimally invasive surgical atrial fibrillation ablation: separating fact from myth (letter to the editor). J Cardiovasc Electrophysiol 2013;24:E12-3 Van Rijsingen IA, Nannenberg EA, Arbustini E, Elliott PM, Mogensen J, Ast JF, Van der Kooi AJ, Van Tintelen JP, Van den Berg MP, Grasso M, Serio A, Jenkins S, Rowland C, Richard P, Wilde AA, Perrot A, Pankuweit S, Zwinderman AH, Charron P, Christiaans I, Pinto YM Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers. Eur J Heart Fail 2013;15: Rienstra M, Lyass A, Murabito JM, Magnani JW, Lubitz SA, Massaro JM, Elinor PT, Benjamin EJ Reciprocal relations between physical disability, subjective health, and atrial fibrillation: The Framingham Heart Study. Am Heart J 2013;1:171-8 Assa S, Gansevoort RT, Westerhuis R, Kobold AC, Voors AA, De Jong PE, Bakker SJ, Franssen CF Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin 1 measured by sensitive assay in hemodialyses patients. Clin Res Cardiol 2013;102: Maggioni AP, Dahlstrom U, Filippatos G,, Voors AA, et al EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESH-HF Pilot) Eur J Heart Fail 2013;7:808-17

10 Meyer S, Van der Meer P, Van Deursen VM, Jaarsma T, Van Veldhuisen DJ, Van der Wal MHL, Hillege HL, Voors AA Neurohormonal and clinic sex differences in heart failure. Eur Heart J 2013;32: Van der Linde D, Andrinopoulou ER, Oechslin EN,, Pieper PG, et al Congenital valvular aortic stenosis in Young adults: predictors for rate of progression of stenosis and aortic dilatation. Int J Cardiol 2013;2: Ebels T Atrial septal defect closure in the adult remains controversial, editorial comments. Eur J Cardiothorac Surg 2013;43:757-8 Lok DJ, Lok SI, Bruggink-André de la Porte PW, Badings E, Lipsic E, Van Wijngaarden J, De Boer RA, Van Veldhuisen DJ, Van der Meer P Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure. Clin Res Cardiol 2013;102: Gheorghiade M, Patel K, Filippatos G, Anker SD, Van Veldhuisen DJ, Cleland JGF, Metra M, Aban IB, Greene SJ, Adams KF, McMurray JJV, Ahmed A Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial. Eur J Heart Fail 2013;5:551-9 Wieringa WG, Lexis CPH, Dierckx GFH, Lipsic E, Tan ES, Schurer RAJ, Van der Werf HW, Van den Heuvel AFM, Suurmeijer AJH, Zijlstra F, De Smet BJGL, Pundziute G The feasibility of optical coherence tomography guided thrombus aspiration in patients with non-stelevation myocardial infarction after initial conservative therapy a pilot study. Int J Cardiol 2013;5: Schurer RA, Douglas YL, Van der Werf HW, Natour E, Van den Heuvel AF Use of the MitraClip in high-risk patients with severe heart failure: are we ready to identify the right candidate? Eur J Heart Fail 2013;15:715-6 Lok DJ, Klip IT, Lok SI, Bruggink-André de la Porte PW, Badings E, Van Wijgaarden J, Voors AA, De Boer RA, Van Veldhuisen DJ, Van der Meer P Incremental prognostic power of novel biomarkers (growth-differentiation factor-15, high-sensitivity C- reactive protein, galectin-3, and high-sensitivity troponin-t) in patients with advanced chronic heart failure. Am J Cardiol 2013;112:831-7 Mulder BA, Van Veldhuisen DJ, Crijns HJGM, Tijssen JGP, Hillege HL, Alings M, Rienstra M, Groenveld HF, Van den Berg MP, Van Gelder IC, for the RACE II investigators Lenient vs. Strict rate controle in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study. Eur J Heart Fail 2013;15:1311-8

11 Pundziute G Can coronary calcium scoring and computed tomography angiography serve as a gatekeeper for invasive coronary angiography in patients with new-onset heart failure? Eur J Heart Fail 2013;15:963-5 Juarez-Orozco LE, Glauche J, Alexanderson E, Zeebregts CJ, Boersma HH, Glaudemans AWJM, Dierckx RA, Van Veldhuisen DJ, Tio RA, Slart RHJA Myocardial perfusion reserve in spared myocardium: correlation with infarct size and left ventricular ejection fraction. Eur J Nucl Med Mol Imaging 2013;8: Zannad F, Garcia AA, Anker SD,, Voors AA, et al Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail 2013;10: Kaufmann SG, Westenbroek RE, Maass AH, Lange V, Renner A, Wischmeyer E, Bonz A, Muck J, Ertl G, Catterall WA, Scheuer T, Maier SKG Distribution and function of sodium channel subtypes in human atrial myocardium. J Mol Cell Cardiol 2013;61: Seferovic PM, Stoerk S, Filippatos G,, Van Veldhuisen DJ, et al Organization of heart failure management in European Society of Cardiology members countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups. Eur J Heart Fail 2013;15: Voors AA, Dorhout B, Van der Meer P The potential role of valsartan+ahu377 (LCZ696) in the treatment of heart failure. Expert Opin Invest Drugs 2013;8: Wolff D, Van Melle JP, Berger RM, Ebels T The Fontan operation starts with the cavopulmonary shunt. J Am Coll Cardiol 2013;61: Eschalier R, McMurray JJ, Swedberg K, Van Veldhuisen DJ, Krum H, Pocock SJ, Shi H, Vincent J, Rossignol P, Zannad F, Pitt B; EMPHASIS-HF investigators Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (eplerenone in mild patients hospitalization and survival study in heart failure). J Am Coll Cardiol 2013;62: Kerstjens-Frederikse WS, Bongers EMHF, Roofthooft MTR, Leter EM, Douwes JM, Van Dijk A, Vonk- Noordegraaf A, Dijk-Bos KK, Hoefsloot LH, Hoendermis ES, Gille JJP, Sikkema-Raddats B, Hofstra RMW, Berger RMF TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension. J Med Genet 2013;8:500-6 Van Gelder IC, Van Veldhuisen DJ, Lip GY New oral anticoagulants in heart failure. Eur J Heart Fail 2013;15:966-73

12 Neyt M, Van den Bruel A, Smit Y, De Jonge N, Erasmus M, Van Dijk D, Vlayen J Cost-effectiveness of continuous-flow left ventricular assist devices. Int J Technol Assess Health Care 2013;29: Paul DS, Albers CA, Rendon A, Voss K, Stephens J, HaemGen Consortium, Van der Harst P, Chambers JC, Soranzo N, Ouwehand WH, Deloukas P Maps of open chromatin highlight cell type-restricted patterns of regulatory sequence variation at hematological trait loci. Genome Res 2013;23: Den Hoed M, Eijgelsheim M, Esko T,, Van der Harst P, Van Gilst WH, et al Identification of heart rate associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet 2013;6:621 Sikkema-Raddats B, Johansson LF, De Boer EN, Almomani R, Boven LG, Van den Berg MP, Van Spaendonck-Zwarts KY, Van Tintelen JP, Sijmons RH, Jongbloed JDH, Sinke RJ Targeted next-generation sequencing can replace sanger sequencing in clinical diagnostics. Hum Mutat 2013;34: Lam MK, Al-Ansari S, Van Dam GM, Tio RA, Breek JC, Slart RH, Hillebrands JL, Zeebregts CJ Single chain VEGF/Cy5.5 targeting VEGF receptors to indicate atherosclerotic plaque instability. Mol Imaging Biol 2013;15: Fokkema ML, Kleijn L, Van der Meer P, Belonje AM, Achterhof SK, Hillege HL, van t Hof A, Jukema JW, Peels HO, Henriques JP, Ten Berg JM, Vos J, Van Gilst WH, Van Veldhuisen DJ, Voors AA Long term effects of epoetin alfa in patients with ST-elevation myocardial infarction. Cardiovasc Drugs Ther 2013;27:433-9 De Boer RA, Edelmann F, Cohen-Solal A, Mamas MA, Maisel A, Pieske B Galectin-3 in heart failure with preserved ejection fraction. Eur J Heart Fail 2013;15: Riezebos-Brilman A, Verschuuren EAM, Van Son WJ, Van Imhoff GW, Brügemann J, Blokzijl H, Niesters HGM The clinical course of hepatitis E virus infection in patients of a tertiary Dutch hospital over a 5 yearperiod. J Clin Virol 2013;3: Brouwers FP, Van Gilst WH, Van Veldhuisen DJ The changing face of heart failure: are we really making progress? Eur J Heart Fail 2013;15:960-2 Bourge RC, Fleg JL, Fonarow GC,, Van Veldhuisen DJ, et al Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. Am J Med 2013;8:701-8 Voors AA, Van der Meer P Heart failure in the young. J Am Coll Cardiol 2013;20: Groenink M, Den Hartog AW, Franken R, Radonic T, De Waard V, Timmermans J, Scholte AJ, Van den Berg MP, Spijkerboer AM, Marquering HA, Zwinderman AH, Mulder BJM

13 Losartan reduced aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J 2013;34: Arrigoni SC, Willems TP, Mungroop HE, Van den Heuvel F, Ebels T Lusoria flap for the management of aortic coarctation in an eight-year-old child. World J Pediatr Congenit Heart Surg 2013;4:302-4 De Jong AM, Van Gelder IC, Vreeswijk-Baudoin I, Cannon MV, Van Gilst WH, Maass AH Atrial remodeling is directly related to end-diastolic left ventricular pressure in a Mouse model of ventricular pressure overload. PLoS One 2013;8:e72651 Mehmood SI, Borleffs JCC, Tio RA Medical students in search of research? Med Teach 2013;10:873-4 Maass AH, Van Veldhuisen DJ Contemporary use of devices in heart failure. Clin Pharmacol Ther 2013;94:433-5 De Boer RA, Van der Velde AR Galectin-3: a new biomarker for heart failure progression and prognosis. J Lab Med 2013;5: Koyak Z, De Groot JR, Bouma BJ, Van Gelder IC, Budts W, Zwinderman AH, Mulder BJ Symptomatic but not asymptomatic non-sustained ventricular tachycardia is associated with appropriate implantable cardioverter therapy in tetralogy of Fallot. Int J Cardiol 2013;167: Schuuring MJ, Vis JC, Van Dijk AP, Van Melle JP, Vliegen HW, Pieper PG, Sieswerda GT, De Bruin-Bon RH, Mulder BJ, Bouma BJ Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial. Eur J Heart Fail 2013;14:690-8 Hyttel-Sorensen S, Austin T, Van Bel F, Benders M, Claris O, Dempsey E, Fumagalli M, Greisen G, Grevstad B, Hagmann C, Hellström-Westas L, Lemmers P, Lindschou J, Naulaers G, Van Oeveren W, Pellicer A, Pichler G, Roll C, Skoog M, Winkel P, Wolf M, Gluud C A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial. Trials 2013;14:120 Munneke AJ, Rakhorst G, Petersen AH, Van Oeveren W, Prop J, Erasmus ME Flush at room temperature followed by storage on ice creates the best lung graft preservation in rats. Transpl Int 2013;26: Rienstra M, Van Gelder IC Ventricular rate control of atrial fibrillation in heart failure. Heart Fail Clin 2013;9:

14 Van Veldhuisen DJ, Van Gelder IC, Ahmed A, Gheorghiade M Digoxin for patients with atrial fibrillation and heart failure: paradise lost or not? Eur Heart J 2013;34: Vis JC, Duffels MG, Mulder P, De Bruin-Bon RH, Bouma BJ, Berger RM, Hoendermis ES, Van Dijk AP, Mulder BJ Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart disease. Int. J. Cardiol 2013;164:64-9 Koyak Z, Kroon B, De Groot JR, Wagenaar LJ, Van Dijk AP, Mulder BA, Van Gelder IC, Post MC, Mulder BJ, Bouma BJ Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias. Am J Cardiol 2013;112: Gheorghiade M, Marti CN, Sabbah HN, Roessig L, Greene SJ, Böhm M, Burnett JC, Campia U, Cleland JG, Collins SP, Fonarow GC, Levy PD, Metra M, Pitt B, Ponikowski P, Sato N, Voors AA, Stasch JP, Butler J Soluble guanylate cyclase: a potential therapeutic target for heart failure. Heart Fail Rev 2013;18: Gottlieb SS, Stebbins A, Voors AA, Hasselblad V, Ezekowitz JA, Califf RM, O Connor CM, Starling RC, Hernandez AF Effects of nesiritide and predictors of urine output in acute decompensated heart failure; results from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure). J Am Coll Cardiol 2013;13: Brouwers FP, De Boer RA, Van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, Hillege HL, Van Veldhuisen DJ, Van Gilst WH Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J 2013;34: McMurray JJ, Anand IS, Diaz R, Maggioni AP, O Connor C, Pfeffer MA, Solomon SD, Tendera M, Van Veldhuisen DJ, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB; on behalf of the RED-HF Committees Investigators Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF). Eur J Heart Fail; 2013;15: Nauta FL, Scheven L, Meijer E, Van Oeveren W, De Jong PE, Bakker SJ, Gansevoort RT Glomerular and tibular damage markers in individuals with progressive albuminuri. Clin J Soc Nephrol 2013;8: Fiuzat M, O Connor CM, Gueyffier F,, Voors AA, et al Biomarker-guided therapies in heart failure: a forum for unified strategies. J Card Fail 2013;8:592-9 Yu L, Ruifrok WP, Meissner M, Bos EM, Van Goor H, Sanjabi B, Van der Harst P, Pitt B, Goldstein IJ, Koerts JA, Van Veldhuisen DJ, Bank RA, Van Gilst WH, Silljé HH, De Boer RA Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis. Circ Heart Fail 2013;6:107-17

15 Damman K Neutrophil gelatinase-associated lipocalin and worsening renal function in acute heart failure: the plot thickens. J Cardiovasc Med 2013;9:636-6 Kraai IH, Vermeulen KM, Luttik MLA, Hoekstra T, Jaarsma T, Hillege HL Preferences of heart failure patients in daily clinical practice: quality of life or longevity? Eur J Heart Fail 2013;10: Liu H, Luiten PGM, Eisel ULM, De Jongste MJL, Schoemaker RG Depression after myocardial infarction: TNF-alpha-induced alterations of the blood-brain barrier and its putative therapeutic implications. Neurosc Biobeh Rev 2013;4: Arsov S, Trajceska L, Van Oeveren W, Smit AJ, Dzekova P, Stegmayr B, Sikole A, Rakhorst G, Graaff R Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients. Artif Organs 2013;37:E Holmes MV, Simon T, Exeter HJ,, Van der Harst P, et al Secretory phospholipase A(2)-IIA and cardiovascular disease. J Am Coll Cardiol 2013;21: Verweij N, Mahmud H, Mateo Leach I, De Boer RA, Brouwers FP, Yu H, Asselbergs FW, Struck J, Bakker SJ, Gansevoort RT, Munroe PB, Hillege HL, Van Veldhuisen DJ, Van Gilst WH, Silljé HH, Van der Harst P Genome-wide association study on plasma levels of midregional-proadrenomedullin and C-terminal-proendothelin-1. Hypertension 2013;61:602-8 Calvier L, Miana M, Reboul P, Cachofeiro V, Martinez-Martinez E, De Boer RA, Poirier F, Lacolley P, Zannad F, Rossignol P, López-Andrés N Galectin-3 mediates aldosterone-induced vascular fibrosis. Arterioscler Thromb Vasc Biol 2013;33:67-75 Groenweg JA, Van der Zwaag PA, Nordkamp LRAO,, Wiesfeld ACP, et al Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 Task Force criteria with inclusion of non-desmosomal phospholamban mutation carriers. Am J Cardiol 2013;8: Backus BE, Six AJ, Kelder JC,, Tio R, et al A prospective validation of the HEART score for chest pain patients at the emergency department. Int J Cardiol 2013;3: Dullaart RPF, Van Pelt LJ, Kwakernaat AJ, Dikkeschei BD, Van der Horst ICC, Tio RA Plasma lipoprotein-associated phospholipase A(2) mass is elevated in STEMI compared to non-stemi patients but does not discriminate between myocardial infarction and non-cardiac chest pain. Clin Chim Acta 2013;424: Voors AA Trial data resolve gaps in evidence-based treatment. Nat Rev Cardiol 2013;10:67-8

16 Pahari DR, Gu YL, Van Oeveren W, El-Essawi A, Harringer W, Brouwer RM Effect of minimized perfusion circuit on brain injury markers carnosinase and brain-type fatty binding protein in coronary artery bypass grafting patients. Artif Organs 2013;37: Van der Velde AR, Gullestad L, Ueland T, Aukrust P, Guo Y, Adourian AS, Muntendam P, Van Veldhuisen DJ, De Boer RA Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH. Circ Heart Fail 2013;6: Brouwer CA, Postma A, HLH Hooimeijer, Smit AJ, Vonk JM, Van Roon AM, Van den Berg MP, Dolsma WV, Lefrandt JD, Bink-Boelkens MTE, Zwart N, De Vries EGE, Tissing WJE, Gietema JA Endothelial damage in long-term survivors of childhood cancer. J Clin Oncol 2013;31: Kirchhof P, Breithardt G, Aliot E,, Van Gelder IC, et al Personalized management of atrial fibrillation: proceedings from the fourth Atrial Fibrillation competence NETwork/European heart Rhythm Association consensus conference. Europace 2013;11: Damman P, Kampinga MA, Van der Horst ICC, Woudstra P, Grundeken MJ, Kuijt WJ, Harskamp RE, Nijsten MWN, Zijlstra F, Tijssen JGP, De Smet BJ, De Winter RJ Multiple biomarkers for the prediction of short and long-term mortality after ST-segment elevation myocardial infarction: the Amsterdam Groningen collaboration. J Thromb Thrombolys 2013;1:42-6 Gheorghiade M, Vaduganathan M, Fonarow GC, Greene SJ, Greenberg BH, Liu PP, Massie BM, Mehra MR, Metra M, Zannad F, Cleland JGF, Van Veldhuisen DJ, Shah AN, Butler J Anticoagulation in heart failure: current status and future direction. Heart Fail Rev 2013;6: Mahmud H, Ruifrok WP, Westenbrink BD, Cannon MV, Vreeswijk-Baudoin I, Van Gilst WH, Silljé HH, De Boer RA Suicidal erythrocyte death, eryptosis, as a novel mechanism in heart failure-associated anemia. Cardiovasc Res 2013;98:37-46 Van Spaendonck-Zwarts KY, Van Rijsingen IAW, Van den Berg MP, Lekanne Deprez RH, Post JG, Van Mil AM, Asselbergs FW, Christiaans I, Van Langen IM, Wilde AAM, De Boer RA, Jongbloed JDH, Pinto YM, Van Tintelen JP Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years experience. Eur J Heart Fail 2013;15: Pellicer A, Greisen G, Benders M, Claris O, Dempsey E, Fumagalli M, Gluud C, Hagmann C, Hellström- Westas L, Hyttel-Sorensen S, Lemmers P, Naulaers G, Pichler G, Roll C, Van Bel F, Van Oeveren W, Skoog M, Wolf M, Austin T The SafeBoosC phase II randomized clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants. Neonatology 2013;104:171-8

17 Camm AJ, Lip GY, Caterina RD,., Van Gelder IC, et al Actualización de las guias de la Sociedad Europea de Cardiologia (ESC) para el manejo de la fibrilación auricular de 2010 Elaborado en colaboración con la Asociación Europea del Ritmo Cardiaco. Rev Esp Cardiol 2013;66:54.e1-44.e24 Groenveld HF, Tijssen JG, Crijns HJ, Van den Berg MP, Hillege HL, Alings M, Van Veldhuisen DJ, Van Gelder IC; RACE II Investigators Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation). J Am Cardiol 2013;61:741-8 Wolff D, Ebels T, Van Melle JP N-terminal pro brain natriuretic hormone in Fontan patients: heart failure or circulatory failure? Eur J Heart Fail 2013;15:602-3 Franken R, Den Hartog AW, De Waard V, Engele L, Radonic T, Lutter R, Timmermans J, Scholte AJ, Van den Berg MP, Zwinderman AH, Groenink M, Mulder BJM Circulating transforming growth factor-β as a prognostic biomarker in Marfan syndrome. Int J Cardiol 2013;168: Bouma W, Wijdh-den Hamer IJ, Klinkenberg TJ, Kuijpers M, Bijleveld A, Van der Horst IC, Erasmus ME, Gorman JH 3rd, Gorman RC, Mariani MA Mitral valve repair for post-myocardial infarction papillary muscle rupture. Eur J Cardiothorac Surg 2013;44: Pozzoli A, Klinkenberg TJ, De Maat GE, Mariani MA Cardiac dynamic magnetic resonance of a giant lung carcinoma invading the left atrium: do not let the imaging fool you. Eur J Cardiothoracic Surg 2013;44:377-8 Buijs RVC, Willems TP, Tio RA, Boersma HH, Tielliu IFJ, Slart RHJA, Zeebregts CJ Calcification as a risk factor for rupture of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2013;5:542-8 Widder J, Klinkenberg TJ, Ubbels JF, Wiegman EM, Groen HJ, Langendijk JA Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy? Radiother Oncol 2013;107: Munneke AJ, Rakhorst G, Petersen AH, Van Oeveren W, Prop J, Erasmus ME Flush at room temperature followed by storage on ice creates the best lung graft preservation in rats. Transpl Int 2013;26: Van De Wauwer C, Munneke AJ, Engels GE, Berga FM, Rakhorst G, Nijsten MW, Mariani MA, Erasmus ME In situ lung perfusion is a valuable tool to assess lungs from donation after circulatory death donors category I-II. Transpl Int 2013;26:485-92

18 Snijder PM, De Boer RA, Bos EM, Van den Born JC, Ruifrok WP, Vreeswijk-Baudoin, Van Dijk MC, Hillebrands JL, Leuvenink HG, Van Goor H Gaseous hydrogen sulfide protects against myocardial ischemia-reperfusion injury in mice partially independent from hypometabolism. PLoS One 2013;8:e63291 De Jong AM Maass AH, Oberdorf-Maass SU, De Boer RA, Van Gilst WH, Van Gelder IC Cyclical stretch induces structural changes in atrial myocytes. J Cell Mol Med 2013;17: Codd V, Nelson CP, Albrecht E,, De Boer RA,, Van Veldhuisen DJ,, Van der Harst P, et al Identification of seven loci affecting mean telomere lenght and their association with disease. Nat Genet 2013;45:422-7 Den Hoed M, Eijgelsheim M, Esko T,, De Boer RA, et al Identification of heart rate-associated loci and their effect on cardiac conduction and rhythm disorders. Nat Genet 2013;45: Zuidersma M, Conradi HJ, Van Melle JP, Ormel J, De Jonge P Self-reported depressive symptoms, diagnosed clinical depression and cardiac morbidity and mortality after myocardial infarction. Int J Cardiol 2013;167: Buijs RV, Willems TP, Tio RA, Boersma HH, Tielliu IF, Slart RH, Zeebregts CJ Current state of experimental imaging modalities for risk assessment of abdominal aortic aneurysm. J Vasc Surg 2013;57:851-9 Den Hartog AW, Franken R, De Witte P, Radonic T, Marquering HA, Van der Steen WE, Timmermans J, Scholte AJ, Van den Berg MP, Zwinderman AH, Mulder BJM, Groenink M Aortic disease in patients with Marfan syndrome: aortic volume assessment for surveillance. Radiology 2013;268:370-7 Kirchhof P, Breithardt G, Aliot E.,, Van Gelder IC, et al. Personalized management of atrial fibrillation: Proceedings from the fourth atrial fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace 2013;15: Van Rijsingen IA, Bakker A, Azim D, Hermans-van Ast JF, Van der Kooi AJ, Van Tintelen JP, Van den Berg MP, Christiaans I, Lekanne Dit Deprez RH, Wilde AA, Zwinderman AH, Meijers JC, Grootemaat EA, Nieuwland R, Pinto YM, Pinto-Sietsma JS Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications. Int J Cardiol 2013;168:472-7 Gheorghiade M, Vaduganathan M, Greene SJ, Mentz RJ, Adams KF Jr, Anker SD, Arnold M, Baschiera F, Cleland JG, Cotter G, Fonarow GC, Giordano C, Metra M, Misselwitz F, Mühlhofer E, Nodari S, Frank Franken R, Den Hartog AW, Van de Riet L, Timmermans J, Scholte AJ, Van den Berg MP, De Waard V, Zwinderman AH, Groenink M, Yip JW, Mulder BJM Clinical features differ substantially between Caucasian and Asian populations of Marfan syndrome Circulation Journal 2013;77:2793-8

19 Pieper PG, Balci A, Aarnoudse JG, Kampman MA, Sollie KM, Groen H, Mulder BJ, Oudijk MA, Roos- Hesselink JW, Cornette J, Van Dijk AP, Spaanderman ME, Drenthen W, Van Veldhuisen DJ; ZAHARA II investigators Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease. Circulation 2013;128: De Maat GE, Pozzoli A, Scholten MF, Hillege HL, Van Gelder IC, Alfieri OR, Benussi S, Mariani MA Surgical minimally invasive pulmonary vein isolation for lone atrial fibrillation: midterm results of a multicenter study. Innovations (Phila) 2013;8:410-5 Yin M, Westenbrink B, Meissner M, Van Gilst WH, De Boer RA Variable effects of anti-diabetic drugs in animal models of myocardial ischemia and remodeling: a translational perspective for the cardiologist. Int J Cardiol 2013;169: Yu H, Tigchelaar W, Lu B, Van Gilst WH, e Boer RA, Westenbrink BD, Silljé HH AKIP1, a cardiac hypertrophy induced protein that stimulates cardiomyocyte growth via the Akt pathway. Int J Mol Sci 2013;14: Kuijpers M, Klinkenberg TJ, Bouma W, De Jongste MJ, Mariani MA Single-port one-stage bilateral thorascopic sympathicotomy for severe hyperhidrosis: prospective analysis of a standardized approach. J Cardiothorac Surg 2013;6:216 Pozzoli A, De Maat GE, Hillege HL, Boogaard JJ, Natour E, Mariani MA Severe thrombocytopenia and its clinical impact after implant of the stentless Freedom Solo bioprosthesis. Ann Thorac Surg 2013;96: Altena R, Van Veldhuisen DJ Heart matters: cardiovascular complications related to cancer treatment. Fut Oncol 2013;2: Sandker SC, Mecozzi G, Van Buiten A, Mariani MA, Buikema H, Grandjean JG Adventitial dissection: a simple and effective way to reduce radial artery spasm in coronary bypass surgery. Interact Cardiovasc Thorac Surg 2013;17:784-9 Van Oeveren W Obstacles in haemocompatibility testing. Scientifica (Cairo) 2013;2013: Akkerman OW, Van Altena R, Klinkenberg T, Brouwers AH, Bongaerts AHH, Van der Werf TS, Alffenaar JW Drug concentration in lung tissue in multidrug-resistant tuberculosis. Eur Resp J 2013;6: Buikema JW, Van der Meer P, Sluijter JPG, Domian IJ Concise review: engineering myocardial tissue: the convergence of stem cells biology and tissue engineering technology.

20 Stem Cells 2013;12: Meyer S, Van der Meer P, Massie BM,, Voors AA, et al Sex-specific acute heart failure phenotypes and outcomes from PROTECT. Eur J Heart Fail 2013;12: Robbers LFHJ, Delewi R, Nijveldt R,, Van der Vleuten PA, Tio RA, et al Myocardial infarct heterogeneity assessment by late gadolinium enhancement cardiovascular magnetic resonance imaging shows predictive value for ventricular arrhythmia development after acute myocardial infarction. Eur Heart J Cardiovasc Imaging 2013;12: Kwakernaak AJ, Waanders F, Slagman MC, Dokter MM, Laverman GD, De Boer RA, Navis G Sodium restriction on top of renin-angiotensin-aldosterone system blockade increases circulating levels of N-acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients. J Hypert 2013;31: Yu H, Tigchelaar W, Koonen DP, Patel HH, De Boer RA, Van Gilst WH, Westenbrink BD, Silljé HH AKIP1 expression modulates mitochondrial function in rat neonatal cardiomyocytes. PLoS One 2013;8:e80815